乳糖菌 (Lacticaseibacillus rhamnosus) 通过限制肠道核酸吸收来缓解高尿血症
Pin Chen1, Huan Cheng1,2,3, Shiguo Chen1,2,3
1College of Biosystems Engineering and Food Science, National-Local Joint Engineering Laboratory of Intelligent Food Technology and Equipment, Zhejiang Key Laboratory of Agri-food Resources and High-value Utilization, Zhejiang University, Hangzhou 310058, China. chenjianle@zju.edu.cn.
一种新型益生菌Lacticaseibacillus rhamnosus (L. rhamnosus) 通过限制肠道纯素的吸收,降低尿酸. 这一发现为通过肠道微生物群调节来管理高尿路血症提供了新的策略.
科学领域:
- 微生物学 微生物学
- 代谢障碍 代谢障碍 代谢障碍
- 胃肠病学 胃肠病学
背景情况:
- 超尿路血症是一种日益严重的代谢障碍.
- 目前的治疗方法侧重于尿酸的分泌或降解,忽视了上游调节.
- 肠道微生物群在纯素代谢中的作用需要进一步探索.
研究的目的:
- 为了研究一种新的益生菌菌株,用于治疗高尿血症.
- 阐明益生菌减少尿酸的作用机制.
- 探索通过肠道微生物群对氨酸代谢的上游调节.
主要方法:
- 隔离和鉴定一种核酸降解益生菌菌株Lacticaseibacillus rhamnosus (L. rhamnosus).
- 在超尿血症大鼠模型中评估尿酸降低效应.
- 多组学分析,Caco-2细胞检测,基因克隆和酶检测以确定机制.
主要成果:
- L. rhamnosus显著降低了血清尿酸盐水平在高尿血症大鼠.
- 益生菌的作用独立于脏尿酸运输体表达.
- L. rhamnosus利用细胞内核酸酸酶将核酸转化为吸收不良的纯素基,限制肠道吸收和肝脏基质供应以合成尿酸盐.
结论:
- L. rhamnosus通过一种新的基质限制机制缓解高尿血症.
- 这项研究为治疗纯素代谢障碍的微生物群干预提供了新的见解.
- 这些发现支持L. rhamnosus作为高尿路血症的潜在治疗剂的发展.
更多相关视频
10:24NMR-Based Activity Assays for Determining Compound Inhibition, IC50 Values, Artifactual Activity, and Whole-Cell Activity of Nucleoside Ribohydrolases
Published on: June 30, 2019
10:25Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
Published on: November 22, 2024
相关概念视频
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Constipation-Predominant IBS
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
Drugs for Treatment of Ulcerative Colitis in IBD
